Mesoblast Limited (Nasdaq: Meso; ASX: MSB), world leader in allogeneous cellular medicines for inflammatory diseases, it today repeated that the allogeneous cell therapy products are made of US donors and referred to as American originated products. Ryoncil ® (Remestem cell L) is the only allogeneous mesenchymal stromal cell therapy approved By US Food and Drug […]
